FAS 161 Debuts to Clarify Derivatives

By Tammy Whitehouse2008-03-25T00:00:00

lock icon THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.

Become a Member

News and analysis for the well-informed compliance or audit exec. Select an option and click continue.

Annual Membership $499 Value offer

Full price one year membership with auto-renewal.

Membership $599

One-year only, no auto-renewal.

Access CW Newsletters and CPE webcasts. REGISTER FOR LIMITED FREE ACCESS

Already a Compliance Week member?

Article
Uncertainty in Derivatives Legislation Looms Large

2010-07-07T00:00:00Z By Tammy Whitehouse
News Brief
Becton Dickinson pays $175M for misleading investors about flawed IV pump system

2024-12-18T18:08:00Z By Adrianne Appel

Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
Premium
Survey: Organizations broadly adopting AI, with varied governance

2024-12-16T19:23:00Z By Adrianne Appel

The majority of businesses are using AI and doing so without governance–a compliance gap that poses extreme risks, a new survey by Compliance Week and GAN Integrity found. A webinar will discuss why it is crucial to have AI governance, how to implement it, and what strategies to strengthen programs. ...